NPWA Stock Overview
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Smith & Nephew plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£22.40 |
| 52 Week High | UK£29.80 |
| 52 Week Low | UK£20.20 |
| Beta | 0.51 |
| 1 Month Change | -9.68% |
| 3 Month Change | -10.40% |
| 1 Year Change | -16.42% |
| 3 Year Change | -31.71% |
| 5 Year Change | -34.12% |
| Change since IPO | 46.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| NPWA | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -0.9% | -2.1% | -0.8% |
| 1Y | -16.4% | -3.3% | 1.0% |
Return vs Industry: NPWA underperformed the German Medical Equipment industry which returned -3.3% over the past year.
Return vs Market: NPWA underperformed the German Market which returned 1% over the past year.
Price Volatility
| NPWA volatility | |
|---|---|
| NPWA Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NPWA has not had significant price volatility in the past 3 months.
Volatility Over Time: NPWA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1856 | 18,452 | Deepak Nath | www.smith-nephew.com |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Smith & Nephew plc Fundamentals Summary
| NPWA fundamental statistics | |
|---|---|
| Market cap | €9.82b |
| Earnings (TTM) | €247.17m |
| Revenue (TTM) | €5.21b |
39.7x
P/E Ratio1.9x
P/S RatioIs NPWA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NPWA income statement (TTM) | |
|---|---|
| Revenue | US$5.55b |
| Cost of Revenue | US$1.66b |
| Gross Profit | US$3.89b |
| Other Expenses | US$3.63b |
| Earnings | US$263.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.30 |
| Gross Margin | 70.14% |
| Net Profit Margin | 4.74% |
| Debt/Equity Ratio | 55.3% |
How did NPWA perform over the long term?
See historical performance and comparison